Selenium sulfide and Lovenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Selenium sulfide and Lovenox. Common interactions include liver injury among females and bursitis among males.

The phase IV clinical study analyzes what interactions people who take Selenium sulfide and Lovenox have. It is created by eHealthMe based on reports of 9 people who take Selenium sulfide and Lovenox from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

9 people who take Selenium sulfide and Lovenox together, and have interactions are studied.


What is Selenium sulfide?

Selenium sulfide has active ingredients of selenium sulfide. It is often used in seborrheic dermatitis. eHealthMe is studying from 650 Selenium sulfide users for its effectiveness, alternative drugs and more.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 42,320 Lovenox users for its effectiveness, alternative drugs and more.

Number of Selenium sulfide and Lovenox reports submitted per year:

Selenium sulfide and Lovenox drug interactions.

Common Selenium Sulfide and Lovenox drug interactions by gender *:

female:

  1. Liver injury
  2. Rash
  3. Toxic skin eruption
  4. Collapse of lung
  5. Dizziness
  6. Dyspnoea
  7. Lung carcinoma cell type unspecified stage iv
  8. Lung neoplasm malignant
  9. Pneumonia
  10. Pneumothorax

male:

  1. Bursitis
  2. Carpal tunnel syndrome
  3. Abdominal distension
  4. Cardiac arrest
  5. Cellulitis
  6. Confusional state
  7. Death
  8. Dermatitis contact
  9. Grand mal convulsion
  10. Histoplasmosis disseminated

Common Selenium Sulfide and Lovenox drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Ileus
  2. Abdominal distension
  3. Bursitis
  4. Cardiac arrest
  5. Carpal tunnel syndrome
  6. Cellulitis
  7. Cholecystitis
  8. Confusional state
  9. Grand mal convulsion
  10. Histoplasmosis disseminated

60+:

  1. Liver injury
  2. Rash
  3. Pneumonia
  4. Pneumothorax
  5. Toxic skin eruption
  6. Hypoxia
  7. Pericardial effusion
  8. Collapse of lung
  9. Dizziness
  10. Dyspnoea

* Approximation only. Some reports may have incomplete information.

Do you take Selenium sulfide and Lovenox?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Selenium sulfide and Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Selenium sulfide interactions:

Browse all interactions between Selenium sulfide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lovenox interactions:

Browse all interactions between Lovenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on selenium sulfide and enoxaparin sodium (the active ingredients of Selenium sulfide and Lovenox, respectively), and Selenium sulfide and Lovenox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Selenium sulfide and Lovenox.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: